These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28389391)

  • 41. Case of postural urticaria in a 14-year-old girl.
    Gabrielli S; Le M; Netchiporouk E; Ben-Shoshan M
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34711626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Omalizumab as a treatment option for antihistamine-refractory aquagenic urticaria.
    Kaur S; Jabbal IS; Bhasin AK
    BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35850790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Home self-administration of omalizumab for chronic spontaneous urticaria.
    Denman S; Ford K; Toolan J; Mistry A; Corps C; Wood P; Savic S
    Br J Dermatol; 2016 Dec; 175(6):1405-1407. PubMed ID: 27639259
    [No Abstract]   [Full Text] [Related]  

  • 44. Chronic spontaneous urticaria in an 8-year-old girl treated with omalizumab.
    Ossorio-García L; Jiménez-Gallo D; Albarrán-Planelles C; Arjona-Aguilera C; Linares-Barrios M
    Clin Exp Dermatol; 2016 Dec; 41(8):929-930. PubMed ID: 27761937
    [No Abstract]   [Full Text] [Related]  

  • 45. Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients.
    Vadasz Z; Tal Y; Rotem M; Shichter-Confino V; Mahlab-Guri K; Graif Y; Kessel A; Agmon-Levin N; Maoz-Segal R; Kivity S; Benor S; Lachover-Roth I; Zeldin Y; Stein M; Toker O; Hassoun G; Bezalel-Rosenberg S; Toubi E; Asher I; Sthoeger Z;
    J Allergy Clin Immunol Pract; 2017; 5(6):1743-1745. PubMed ID: 28988786
    [No Abstract]   [Full Text] [Related]  

  • 46. Serial D-dimer plasma levels in a patient with chronic spontaneous urticaria developing resistance to omalizumab.
    Asero R
    Clin Exp Dermatol; 2017 Aug; 42(6):667-669. PubMed ID: 28691309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Omalizumab in An 8-Year-Old Boy With Diabetes Mellitus and Refractory Chronic Spontaneous Urticaria.
    Jesenak M; Ciljakova M; Janickova M; Banovcin P
    J Investig Allergol Clin Immunol; 2019 Apr; 29(2):144-146. PubMed ID: 31017115
    [No Abstract]   [Full Text] [Related]  

  • 48. Responsiveness and minimal important difference of the urticaria control test.
    Ohanyan T; Schoepke N; Bolukbasi B; Metz M; Hawro T; Zuberbier T; Peveling-Oberhag A; Staubach P; Maurer M; Weller K
    J Allergy Clin Immunol; 2017 Dec; 140(6):1710-1713.e11. PubMed ID: 28625805
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy of omalizumab in severe chronic spontaneous urticaria: Real life data from a Greek tertiary center.
    Kyriakou A; Trigoni A; Sotiriadis D; Patsatsi A
    Dermatol Ther; 2018 Nov; 31(6):e12739. PubMed ID: 30194796
    [No Abstract]   [Full Text] [Related]  

  • 50. Tolerance to nonsteroidal anti-inflammatory drugs and alcohol after omalizumab treatment in a patient with chronic urticaria.
    Walters KM; White AA
    Ann Allergy Asthma Immunol; 2016 Nov; 117(5):559-561. PubMed ID: 27788887
    [No Abstract]   [Full Text] [Related]  

  • 51. Successful treatment of refractory cholinergic urticaria with omalizumab.
    Koumaki D; Seaton ED
    Int J Dermatol; 2018 Jan; 57(1):114. PubMed ID: 29057464
    [No Abstract]   [Full Text] [Related]  

  • 52. Omalizumab for chronic spontaneous urticaria: a boon for sufferers, but there are unanswered questions.
    Greaves MW
    Br J Dermatol; 2015 Aug; 173(2):321. PubMed ID: 26346076
    [No Abstract]   [Full Text] [Related]  

  • 53. Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice.
    Bongiorno MR; Crimi N; Corrao S; Allotta A; Arena A; Brusca I; Heffler E; Malara G; Milioto M; Pistone G; Porto M; Raia E; Valenti G
    Ann Allergy Asthma Immunol; 2016 Dec; 117(6):703-707. PubMed ID: 27720581
    [No Abstract]   [Full Text] [Related]  

  • 54. Healing effects of omalizumab in a patient with cholinergic urticaria associated severe dyspeptic complaints.
    Kutlu A; Tanoglu A; Ozturk S
    Chin Med J (Engl); 2015 Jun; 128(11):1559-60. PubMed ID: 26021519
    [No Abstract]   [Full Text] [Related]  

  • 55. Two-week intervals during omalizumab treatment may provide better symptom control in selected patients with chronic urticaria.
    Türk M; Kocatürk E; Cüre K; Yılmaz İ
    J Allergy Clin Immunol Pract; 2018; 6(4):1389-1390. PubMed ID: 29410306
    [No Abstract]   [Full Text] [Related]  

  • 56. Omalizumab therapy for treatment of recalcitrant chronic spontaneous urticaria in an Asian population.
    Kulthanan K; Tuchinda P; Chularojanamontri L; Likitwattananurak C; Ungaksornpairote C
    J Dermatolog Treat; 2017 Mar; 28(2):160-165. PubMed ID: 27388043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased IgE levels are linked to faster relapse in patients with omalizumab-discontinued chronic spontaneous urticaria.
    Ertas R; Ozyurt K; Ozlu E; Ulas Y; Avci A; Atasoy M; Hawro T; Maurer M
    J Allergy Clin Immunol; 2017 Dec; 140(6):1749-1751. PubMed ID: 28870460
    [No Abstract]   [Full Text] [Related]  

  • 58. Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria.
    Finlay AY; Kaplan AP; Beck LA; Antonova EN; Balp MM; Zazzali J; Khalil S; Maurer M
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1715-1721. PubMed ID: 28573683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria.
    Gericke J; Metz M; Ohanyan T; Weller K; Altrichter S; Skov PS; Falkencrone S; Brand J; Kromminga A; Hawro T; Church MK; Maurer M
    J Allergy Clin Immunol; 2017 Mar; 139(3):1059-1061.e1. PubMed ID: 27838346
    [No Abstract]   [Full Text] [Related]  

  • 60. Refractory solar urticaria successfully treated with omalizumab with normalization of phototest.
    Combalia A; Fernández-Sartorio C; Aguilera P
    Actas Dermosifiliogr; 2017; 108(6):593-594. PubMed ID: 28168968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.